Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2024World Journal of Biology Pharmacy and Health SciencesOpen Access

Systematic review on Ocrevus for treatment of multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

SSS. M. Syed Abdul SubuhanWW.Helen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Subuhan et al. (2024) studied this question.

synapsesocial.com/papers/68e5e803b6db64358757c8fehttps://doi.org/10.30574/wjbphs.2024.19.1.0468
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ocrelizumab: a new milestone in multiple sclerosis therapy2018 · 142 citations
  2. 21ISG-016 Ocrelizumab for the treatment of relapsing and primary progressive multiple sclerosis in a national health system: a cost effectiveness analysis2024 · 1 citations
  3. 3Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis2024 · 4 citations
  4. 4Long‐Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real‐World Longitudinal Study2026 · 1 citations
  5. 5Real-world Data on Ocrelizumab Treatment: Efficacy, Safety, and Tolerability Analysis in Patients with Relapsing Remitting and Primary Progressive Multiple Sclerosis in Southeastern Ontario (P2-6.014)2024